ATE551359T1 - Knochenmorphogeneseprotein antagoniste basierend auf dem maturen protein - Google Patents

Knochenmorphogeneseprotein antagoniste basierend auf dem maturen protein

Info

Publication number
ATE551359T1
ATE551359T1 AT99944750T AT99944750T ATE551359T1 AT E551359 T1 ATE551359 T1 AT E551359T1 AT 99944750 T AT99944750 T AT 99944750T AT 99944750 T AT99944750 T AT 99944750T AT E551359 T1 ATE551359 T1 AT E551359T1
Authority
AT
Austria
Prior art keywords
residue
amino acid
residues
protein
mature
Prior art date
Application number
AT99944750T
Other languages
English (en)
Inventor
Mieko Katsuura
Michio Kimura
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh
Application granted granted Critical
Publication of ATE551359T1 publication Critical patent/ATE551359T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT99944750T 1998-10-09 1999-10-04 Knochenmorphogeneseprotein antagoniste basierend auf dem maturen protein ATE551359T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10288103A JP2000119192A (ja) 1998-10-09 1998-10-09 骨誘導因子アンタゴニスト活性を有する成熟型蛋白質
PCT/IB1999/001621 WO2000021998A1 (en) 1998-10-09 1999-10-04 Bone morphogenetic protein antagonist based on the mature protein

Publications (1)

Publication Number Publication Date
ATE551359T1 true ATE551359T1 (de) 2012-04-15

Family

ID=17725844

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944750T ATE551359T1 (de) 1998-10-09 1999-10-04 Knochenmorphogeneseprotein antagoniste basierend auf dem maturen protein

Country Status (11)

Country Link
US (1) US7132397B1 (de)
EP (1) EP1117689B1 (de)
JP (1) JP2000119192A (de)
AT (1) ATE551359T1 (de)
AU (1) AU5756099A (de)
CA (1) CA2345201C (de)
CY (1) CY1112822T1 (de)
DK (1) DK1117689T3 (de)
ES (1) ES2382992T3 (de)
PT (1) PT1117689E (de)
WO (1) WO2000021998A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
CA2104678C (en) 1991-03-11 2002-05-14 Charles M. Cohen Protein-induced morphogenesis
US7811793B2 (en) 1996-12-25 2010-10-12 Biopharma Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Process for preparing purified active monomer of bone-derived factor
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
US8257438B2 (en) * 2005-04-12 2012-09-04 Warsaw Orthopedic, Inc. Methods and devices for preserving motion in an articulating prosthetic disc
DK1948689T3 (da) * 2005-11-18 2012-07-23 Bioph Biotech Entw Pharm Gmbh Højaktivitetsvækstfaktormutanter
US8075562B2 (en) * 2007-06-25 2011-12-13 Wisconsin Alumni Research Foundation Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
EP2602264A1 (de) 2011-12-05 2013-06-12 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH GDF-5-Mutant zur Induzierung der Knorpelbildung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691349A3 (de) * 1994-07-04 1997-09-10 Hoechst Japan Dimere Knochenmorphogeneseproteine und ihre Fragmente und Analoge und sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
CA2345201C (en) 2011-05-24
PT1117689E (pt) 2012-06-01
JP2000119192A (ja) 2000-04-25
ES2382992T3 (es) 2012-06-15
EP1117689A1 (de) 2001-07-25
AU5756099A (en) 2000-05-01
DK1117689T3 (da) 2012-07-09
EP1117689B1 (de) 2012-03-28
CA2345201A1 (en) 2000-04-20
WO2000021998A1 (en) 2000-04-20
CY1112822T1 (el) 2016-02-10
US7132397B1 (en) 2006-11-07

Similar Documents

Publication Publication Date Title
NO985231D0 (no) Forbindelser som fremmer vevsvekst
ATE300613T1 (de) Menschliche, für zyklische nukleotide spezifische phosphodiesterase
ES2130177T3 (es) Tratamiento de poblaciones de celulas.
CY1112822T1 (el) Ανταγωνιστης μορφογενετικων πρωτεϊνων οστων με βαση την ωριμη πρωτεϊνη
DE69713597D1 (de) Zusammensetzungen enthaltend eine kombination von knochenmorphogenetischem protein und parathyroid-ähnlichem peptid
AU7587696A (en) Differentiation-suppressive polypeptide
BR0314270A (pt) Ativação de miostatina com metaloprotease e processos de modulação da atividade da miostatina
JP2016056185A (ja) 改変型TGF−βスーパーファミリータンパク質
ATE252639T1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
KR960701996A (ko) Bmp-11 조성물[bmp-11 compositions]
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
DE69841105D1 (de) Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhöhung von einer entzündungsreaktion
EA199700329A1 (ru) Новый белок и способ его получения
ATE521706T1 (de) Menschliches homolog des drosophilaproteins 'fused'
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
BR9508664A (pt) Vetores retrovirais visados poe expressão de não auto-inativação
EP1501936A4 (de) Cytokin-proteinfamilie
EP0967283A4 (de) Gene, die für proteine mit transglykolysierungsaktivität kodieren.
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE512217T1 (de) 5-substituerte hydantoin racemase, dafür kodierende dna, und verfahren zur herstellung optisch aktiver aminosäure
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
Breipohl et al. Solid phase synthesis of peptide aminoalkylamides development and application of new linking agents
EP1362915A4 (de) Aus nomuraea rileyi stammende ecdysteroid-22-oxidase und system zur häutungshormon-inaktivierung damit
DE59710091D1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
DE60038741D1 (de) Tachykininpeptide, ihre präpeptide und sie kodierende gene